| Product Code: ETC8869753 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Parkinsons Disease Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Parkinsons Disease Market - Industry Life Cycle |
3.4 Poland Parkinsons Disease Market - Porter's Five Forces |
3.5 Poland Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Poland Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Poland Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Poland Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Poland Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Poland Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in Poland |
4.2.2 Advancements in medical research leading to better understanding and treatment options for Parkinson's disease |
4.2.3 Rising awareness among healthcare professionals and patients about early diagnosis and management of Parkinson's disease |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in certain regions of Poland |
4.3.2 High treatment costs associated with Parkinson's disease medications and therapies |
4.3.3 Lack of standardized protocols for Parkinson's disease management in Poland |
5 Poland Parkinsons Disease Market Trends |
6 Poland Parkinsons Disease Market, By Types |
6.1 Poland Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Poland Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Poland Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Poland Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Poland Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Poland Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Poland Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Poland Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Poland Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Poland Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Poland Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Poland Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Poland Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Poland Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Poland Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Poland Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Poland Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Poland Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Poland Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Poland Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Poland Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Poland Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Poland Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Poland Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Poland Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Poland Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Poland Parkinsons Disease Market Export to Major Countries |
7.2 Poland Parkinsons Disease Market Imports from Major Countries |
8 Poland Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis for Parkinson's disease patients in Poland |
8.2 Number of clinical trials and research studies conducted on Parkinson's disease in Poland |
8.3 Percentage of healthcare facilities in Poland offering specialized care for Parkinson's disease |
9 Poland Parkinsons Disease Market - Opportunity Assessment |
9.1 Poland Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Poland Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Poland Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Poland Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Poland Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Poland Parkinsons Disease Market - Competitive Landscape |
10.1 Poland Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Poland Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here